1. Most Discussed
  2. Gainers & Losers
CCE 1.2¢

post from oze

  1. saxien

    2,794 Posts.

    Post a new message

    Posted by: minutoshi Sep 10 2003 11:08:45:687PM
    Reply to post # by Go to Post #

    Previous Respond Message List Next

    Clinical Cell Culture (CCE) makes NATIONAL NEWS as it's CellSpray products stand on the brink of a major breakthrough into the European markets. For more, check out the following news links: http://news.ninemsn.com.au/National/story_51634.asp

    With news of just its contract manufacturing agreement with Cambrex for the manufacture of CellSpray for the European market, one can understand why the market reacted cooly to it today, greatly undervalueing its current true value. If you haven't already, check out this link for the full announcement:

    After all, all it did was just sign an agreement with Cambrex to start producing CellSpray in a different country. But the implications of this announcements are far-reaching, and you have to read it in context. Just who is Cambrex? Cambrex is a multi-national pharmaceutical company with sales of over US$500 million each year! It is currently worth US$24.15 on the NYSE.

    Joining forces with an established company like Cambrex is a coup for Clinical Cell Culture Ltd. Not only are they able to reduce the time CellSpray takes to get to the market with providing the capital and current Good Manufacturing Practices (cGMP) is has already estabished and proven, but it exposes the product to a possible worldwide market, with Cambrex's presence across Europe, Asia and North America.

    This has great implication for the future of Clinical Cell Culture and it would be fantastic to see this company grow with their amazing innovation! Just to put things into context in the next few months, CellSpray expects to launch its product to hospitals in Germany, Austria and Switzerland with a population of approx. 100 million and thirty burns centres. Currently, CellSpray caters only to Australia, with a population of approx. 20 million. Do the maths and you just might realise that this company could quite possibly be worth 5 times its current value by next year. A very good investment if you ask me.

    These thoughts are of my own opinion through my own research done through the various links I have provided, plus the following: www.clinicalcellculture.com and www.cambrex.com Please do your own research and come to your own opinions about the impact of today's announcement.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.